"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

• Status: Completed
• Trial end date: 2015-10-01

Summary

Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB.

• Phase: Phase 4

Details

• Lead Sponsor: American University of Beirut Medical Center
• Treatments: Glycopyrrolate; Neostigmine; Rocuronium